Showing 11,981 - 12,000 results of 38,038 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.14s Refine Results
  1. 11981
  2. 11982

    Individual data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  3. 11983

    Household data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  4. 11984

    Persons with epilepsy data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  5. 11985

    Ivermectin coverage in 2019 and 2021. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  6. 11986

    Individual data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  7. 11987

    Household data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  8. 11988

    Persons with epilepsy data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  9. 11989

    PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  10. 11990

    Characteristics of Included Studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  11. 11991
  12. 11992
  13. 11993
  14. 11994
  15. 11995
  16. 11996
  17. 11997

    RpoS and Indole Signaling Control the Virulence of <i>Vibrio anguillarum</i> towards Gnotobiotic Sea Bass (<i>Dicentrarchus labrax</i>) Larvae by Xuan Li (137217)

    Published 2014
    “…Deletion of <i>rpoS</i> resulted in increased expression of the indole biosynthesis gene <i>tnaA</i> and in increased production of indole. Both <i>rpoS</i> deletion and the addition of exogenous indole (50–100 µM) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene <i>wbfD</i>. …”
  18. 11998

    Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX by Anthi Bouchla (9748362)

    Published 2022
    “…</p>Results<p>The percentage of males was 50 and 66% and the mean age was 65.16 ± 14.24 and 66.33 ± 13.48 years among patients and controls respectively (mean ± SD, p = 0.78). …”
  19. 11999

    Cleaved caspase-9 of regional brain homogenates obtained at 3, 4, 5, and 9 hours after ROSC by Western blot analysis. by Joo Suk Oh (6090998)

    Published 2021
    “…<p>At four and five hours after ROSC, only the hypothermia + VPA group showed significantly decreased cleaved caspase-9 levels compared to the normothermia group both in the hippocampus (A) and the cerebellar vermis (B). …”
  20. 12000